Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Dipeptidyl peptidase IV-resistant [d-Ala2]Glucose-Dependent Insulinotropic Polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats
Can Reta be used instead of Mounjaro
The target is metabolic: insulin sensitivity, visceral and liver fat, lipids, the markers of metabolic health rather than a number on the scale
Medically reviewed by Dr Kathryn Basford Dr Kathryn Basford is a GP based in London
Efficacy and safety of LixiLan, a titratable fixed-ratio combination of Lixisenatide and insulin glargine, versus insulin glargine in type 2 diabetes inadequately controlled on metformin monotherapy: the LixiLan proof-of-concept randomized trial
US$ 21.65
US$ 27.07
US$ 21.49
US$ 26.38
